PROVIDER PROFILE · NPI 1780603803

Albina KroytorP.A.

PRACTICECLARK DERMATOLOGY, LLCSee all providers at this practice →

Physician AssistantStaten Island, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

911

Unique beneficiaries

—

Total services

1,199

Distinct HCPCS

Medicare payment

$67K

Peer benchmark

Total Medicare services vs. 8,690 Physician Assistant providers in NY — top quintile (cohort median 149).

PRESCRIBING · PART D · 2024

Total Rx claims

993

Beneficiaries

—

Total drug cost

$27K

Distinct drugs

Brand share

20.8%

Top prescribed drugs

Ciclopirox Olamine158 claims

Ketoconazole142 claims

Triamcinolone Acetonide122 claims

Betamethasone Dipropionate89 claims

Clindamycin Phosphate59 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

Education$15

Top paying entities

Food and Beverage$2K

Education$15

REFERRAL NETWORK

Where Albina Kroytor's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
TAN, MARY ALDRENE	36	55
STATEN ISLAND UNIVERSITY HOSPITAL	35	70
Richard Urbanek Dermatology · Staten Island, NY	24	178
Jennifer Lambe Pathology · Lexington, MA	24	39
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	13	26

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history